Die Paper zu diesem Podcast:
Juliet Pulliam et al, medRxiv, 2021, "Increased risk of SARS-CoV-2 reinfection associated with emergence of the Omicron variant in South Africa"
Salim S. Karim et al, Lancet, 2021, "Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic"
Aktueller Situationsbericht des Scripps Institute: "Outbreak Info"
Multicenter-Studie zur Wirksamkeit der Booster:
Alasdair Munroe et al, Lancet, 2021, "Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial"